In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on SELLAS Life Sciences Group Inc

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on SELLAS Life Sciences Group Inc
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on SELLAS Life Sciences Group Inc
Maxim Group analyst Jason McCarthy maintained a Buy rating on SELLAS Life Sciences Group Inc (SLS – Research Report) today
Oppenheimer analyst Hartaj Singh initiated coverage with a Buy rating on SELLAS Life Sciences Group Inc (NASDAQ: SLS) today and
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on SELLAS Life Sciences Group Inc
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SELLAS Life
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to SELLAS Life Sciences Group Inc